GleamWall
中文EN

ACBM ACRO BIOMEDICAL CO., LTD.

Services-Amusement & Recreation Services · OTC · SEC CIK 1622996 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-200.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-493.3%
ROIC (approx.)—
Asset turnover0.00x

Leverage & solvency

Liabilities / assets12,292.7%
Debt / equity—
Current ratio0.01x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.00x
Accruals ratio-1.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$0$0
R&D expense—$0
SG&A expense$154,024$37,958
Operating income-$154,024-$37,958
Pretax income-$101,146-$42,297
Income tax$0$0
Net income-$101,146-$42,297
EPS (diluted)0.000.00
Weighted avg. shares (diluted)60.04M60.04M
Balance sheet
Cash & equivalents$4,098$476
Current assets$14,098$5,076
Total assets$14,098$31,974
Current liabilities$401,062$326,946
Total liabilities$401,062$326,946
Shareholders' equity-$386,964-$294,972
Shares outstanding60.04M60.04M
Cash flow statement
Operating cash flow-$196,302-$36,692
Financing cash flow$199,924$36,792
Stock-based compensation—$0

Free plan shows the latest 2 periods; Pro shows all 12 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.